Literature DB >> 23602568

The protein interaction landscape of the human CMGC kinase group.

Markku Varjosalo1, Salla Keskitalo, Audrey Van Drogen, Helka Nurkkala, Anton Vichalkovski, Ruedi Aebersold, Matthias Gstaiger.   

Abstract

Cellular information processing via reversible protein phosphorylation requires tight control of the localization, activity, and substrate specificity of protein kinases, which to a large extent is accomplished by complex formation with other proteins. Despite their critical role in cellular regulation and pathogenesis, protein interaction information is available for only a subset of the 518 human protein kinases. Here we present a global proteomic analysis of complexes of the human CMGC kinase group. In addition to subgroup-specific functional enrichment and modularity, the identified 652 high-confidence kinase-protein interactions provide a specific biochemical context for many poorly studied CMGC kinases. Furthermore, the analysis revealed a kinase-kinase subnetwork and candidate substrates for CMGC kinases. Finally, the presented interaction proteome uncovered a large set of interactions with proteins genetically linked to a range of human diseases, including cancer, suggesting additional routes for analyzing the role of CMGC kinases in controlling human disease pathways.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602568     DOI: 10.1016/j.celrep.2013.03.027

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  78 in total

1.  Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.

Authors:  Michael B Mann; Michael A Black; Devin J Jones; Jerrold M Ward; Christopher Chin Kuan Yew; Justin Y Newberg; Adam J Dupuy; Alistair G Rust; Marcus W Bosenberg; Martin McMahon; Cristin G Print; Neal G Copeland; Nancy A Jenkins
Journal:  Nat Genet       Date:  2015-04-13       Impact factor: 38.330

2.  Solution NMR structures of immunoglobulin-like domains 7 and 12 from obscurin-like protein 1 contribute to the structural coverage of the Human Cancer Protein Interaction Network.

Authors:  Surya V S R K Pulavarti; Yuanpeng J Huang; Kari Pederson; Thomas B Acton; Rong Xiao; John K Everett; James H Prestegard; Gaetano T Montelione; Thomas Szyperski
Journal:  J Struct Funct Genomics       Date:  2014-07-03

3.  Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss.

Authors:  Robert A Hazlitt; Tal Teitz; Justine D Bonga; Jie Fang; Shiyong Diao; Luigi Iconaru; Lei Yang; Asli N Goktug; Duane G Currier; Taosheng Chen; Zoran Rankovic; Jaeki Min; Jian Zuo
Journal:  J Med Chem       Date:  2018-08-24       Impact factor: 7.446

Review 4.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

Review 5.  Proteomic and interactomic insights into the molecular basis of cell functional diversity.

Authors:  Isabell Bludau; Ruedi Aebersold
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-31       Impact factor: 94.444

6.  Combined proximity labeling and affinity purification-mass spectrometry workflow for mapping and visualizing protein interaction networks.

Authors:  Xiaonan Liu; Kari Salokas; Rigbe G Weldatsadik; Lisa Gawriyski; Markku Varjosalo
Journal:  Nat Protoc       Date:  2020-08-10       Impact factor: 13.491

Review 7.  Optogenetically controlled protein kinases for regulation of cellular signaling.

Authors:  Anna V Leopold; Konstantin G Chernov; Vladislav V Verkhusha
Journal:  Chem Soc Rev       Date:  2018-04-03       Impact factor: 54.564

8.  Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3.

Authors:  Martin Golkowski; Gayani K Perera; Venkata Narayana Vidadala; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Shao-En Ong
Journal:  Mol Omics       Date:  2018-02-12

9.  Interactome mapping defines BRG1, a component of the SWI/SNF chromatin remodeling complex, as a new partner of the transcriptional regulator CTCF.

Authors:  Maria Michela Marino; Camilla Rega; Rosita Russo; Mariangela Valletta; Maria Teresa Gentile; Sabrina Esposito; Ilaria Baglivo; Italia De Feis; Claudia Angelini; Tioajiang Xiao; Gary Felsenfeld; Angela Chambery; Paolo Vincenzo Pedone
Journal:  J Biol Chem       Date:  2018-11-20       Impact factor: 5.157

10.  Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity.

Authors:  Mikko Turunen; Jason M Spaeth; Salla Keskitalo; Min Ju Park; Teemu Kivioja; Alison D Clark; Netta Mäkinen; Fangjian Gao; Kimmo Palin; Helka Nurkkala; Anna Vähärautio; Mervi Aavikko; Kati Kämpjärvi; Pia Vahteristo; Chongwoo A Kim; Lauri A Aaltonen; Markku Varjosalo; Jussi Taipale; Thomas G Boyer
Journal:  Cell Rep       Date:  2014-04-18       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.